google-site-verification: google28f501b00d980d5f.html Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market - Vetpol Community

Announcement

Collapse
No announcement yet.

Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market

Collapse
X
Collapse

  • Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market

    Click image for larger version

Name:	campus.png
Views:	2
Size:	77.2 KB
ID:	45587
    New Building Project at the Ceva Sogeval Campus

    2017 will go down in history as the year Ceva Santé Animale (Ceva) achieved growth of 20% and broke the billion euro barrier for the first time with sales of €1.1 billion. This performance consolidates its position as the 6th largest animal health company and leading French multinational in the sector.

    A year of growth based on successful integrations
    In 2017, Ceva grew its business by 20%, achieving turnover of €1.1 billion. Performance was strong across all geographical regions. The global sales are split as follows Europe - 34%, Africa-Middle East-Eastern Europe-Turkey - 19%, North America-Pacific – 16%, Latin America – 15% and Asia – 13%.

    In terms of product portfolios, the Swine business recorded the biggest increase (up 66%, representing 16% of sales) due mainly to the acquisition of 4 ex-Merial vaccines. Ruminants sales were up 40%, (20% of turnover) driven by the acquisition of Brazilian firms Hertape and Inova. Companion Animals sales grew 12%, (29% of turnover), with Poultry up 8%, (35% of turnover).

    Ceva Chairman and CEO, Dr. Marc Prikazsky delighted with these latest results said: “Our strong growth can be explained largely through our most recent acquisitions, Hertape and Inova in Brazil, but equally the purchase of a number of ex-Merial products and the acquisitions of Ebvac, China, Polchem in India and Biovac, France. However, our organic growth was also a driver, achieving an historic 9% increase (at constant scope and exchange rates). This success is due to the hard work of all our teams, in particular those in Libourne, for the smooth integration of these new companies, as well as the R&D, industrial and logistics teams for the development of such innovative new products as Feliscratch by Feliway®, Zeleris® and Smartvac®.”

    Ceva intends to maintain its strong dynamic through innovation and major global investment in its industrial sites
    Dr. Prikazsky adds: “In these times of rapid global change, we need to make the most of our agility to quickly integrate, from today, the new orientations of research in areas such as artificial intelligence, connected agriculture, robotisation, digitalisation, big data, etc. The challenge for the future will be how to integrate these new technologies into our business model. This is a challenge for the agricultural community as a whole, both in France and around the world. In all these areas, once again, Ceva wants to become a first-line reference.”

    Along the lines of its investment last year in Applifarm, a Big Data platform for the ruminants sector, Ceva is looking to develop new services, particularly in hatcheries around its vector-vaccine and in-ovo vaccination equipment developed by its French subsidiary, Ecat-iD.2018 will also see the realisation of three major projects in France under the “Factory of the Future” banner:
    • Construction in Laval, Mayenne of a global centre of expertise in companion animals. Between 2014 and 2020 Ceva will have invested €25 million in the Ceva Sogeval Campus, with €7.5 million of that going towards the construction of an ultramodern 3600m2 campus – including a 1000m2 laboratory and Quality Control building (due to open in February 2018).
    • Construction of a 2000m2 building in Loudéac, Brittany. Ceva has invested €6.8 million in order to integrate a range of dermatological products for Companion animals. In addition to the Feliway® and Adaptil® ranges it will produce the Douxo® range for the European market, with the aim of becoming the world leader in topical dermatology products by 2020 (due to open in May 2018).
    • Construction of a 2600m2 industrial building in Libourne, Gironde. With an investment of €8.5 million the Group hopes to increase storage capacity for vaccines and, at the same time, improve its logistics (due to open in November 2018). This year, Ceva will also initiate a project to examine how to reorganise the entire Libourne site, which includes its head office, with the aim of improving the work environment and encouraging exchange between different services.
    To maintain its constant rhythm of growth, it is imperative that Ceva continues to invest in the future, in innovation, in new sectors like biotechnology and in R&D – particularly in relation to swine and poultry biology,” explains Marc Prikazsky.
    Attached Files
      Posting comments is disabled.

    Article Tags

    Collapse

    Latest Articles

    Collapse

    • Vet sends warning about deadly dog disease
      Kristina Kisbee

      A vet is warning dog owners to be aware where they buy puppies from, after she saved a young puppy from a deadly disease.

      Otter, a Labrador, was brought to see vet Martina Eyre-Brook at her Vets4Pets practice in Cirencester last month for his second set of vaccinations.

      But the 10-week-old, who had only been bought by his owners just days before, was vomiting and suffered from diarrhoea, when he arrived at the practice.

      It...
      Today, 08:01 AM
    • BEVA Congress is for Vet Nurses too
      Kristina Kisbee

      BEVA is reminding vet nurses and vet practices that there is a dedicated nursing stream all day on the Saturday of this year’s Congress 12-15 September 2018. Whether a mixed practice VN or an equine VN it’s the ideal opportunity to top up on some high quality CPD on diagnostic imaging, theatre nursing and the nursing of neonates and colics.

      BEVA Congress is renowned for involving world-leading experts across its extensive science programme and the VN stream is no exception. Tutors
      ...
      Yesterday, 07:15 AM
    • New name and packaging for Equitop® GLME
      Kristina Kisbee

      Boehringer Ingelheim has rebranded its popular equine joint supplement with the launch of Equitop® GLME.

      The joint supplement of choice for professional riders, Equitop GLME (previously known as SERAQUIN GLME), joins the Equitop portfolio of products which also includes Equitop® Myoplast, Boehringer’s market-leading supplement that supports lean muscle growth in horses.

      The eye-catching new packaging clearly distinguishes the product as an Equitop...
      Yesterday, 07:13 AM
    • Ceva launches new fireworks marketing and display pack
      Kristina Kisbee

      Ceva Animal Health, manufacturer of ADAPTIL® and FELIWAY®, has launched a new fireworks marketing and display pack to provide pet owners with information on how to help their pets during the fireworks season.

      The pack includes an informative new leaflet written by leading dog behaviourist, Gwen Bailey, and supported by Blue Cross, Association of Pet Behaviour Counsellors (APBC), Wood Green, Puppy School, International Cat Care and Cats Protection. It features the signs of firework
      ...
      17-08-2018, 08:01 AM
    • State-of-the Art Vehicle Boosts Medivet Vet Blood Service
      Kristina Kisbee

      Medivet’s in-house blood donation service, Vet Blood, has been boosted by the arrival of a state-of-the-art vehicle, equipped with the latest technology to enable it to process, store and freeze blood products and to then deliver them to practices across the UK 24 hours a day, seven days a week.


      To mark its arrival, a Donor Day was held at Medivet Welwyn Garden City on Saturday 11 August. Eight dogs gave blood, including greyhound Tommy, already a donor for Medivet,...
      15-08-2018, 07:30 AM
    • Australian Veterinarian to Receive 2018 WSAVA, Hill’s 'Next Generation' Veterinary Award
      Kristina Kisbee

      Judges recognize veterinary ‘bridge-builder’ and One Health champion


      Dr. Guyan Weerasinghe, an Australian veterinarian working in small animal practice and as a state government veterinary officer, has been announced by the World Small Animal Veterinary Association (WSAVA) and Hill's Pet Nutrition as the winner of the 2018 Next Generation Veterinary Award. The award acknowledges the work of a veterinarian who graduated within the past ten years and who has contributed
      ...
      15-08-2018, 07:24 AM
    Working...
    X